# Lexington Biosciences, Inc. (LXGTF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LXGTF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -120.1K | $ 0 | $ 0 | $ -1.11M |
| 2023 | $ 0 | $ -184.1K | $ 0 | $ 0 | $ -988.8K |
| 2022 | $ 0 | $ -39.7K | $ -712 | $ 0 | $ -811.4K |
| 2021 | $ 0 | $ -369.4K | $ -30.8K | $ 0 | $ -1.82M |
| 2020 | $ 0 | $ -574.4K | $ -388.7K | $ 0 | $ -1.49M |
| 2019 | $ 0 | $ -1.53M | $ -253.2K | $ 843.5K | $ -1.04M |
| 2018 | $ 0 | $ -2.88M | $ -1.99M | $ 270.6K | $ -575.2K |
| 2017 | $ 0 | $ -2.50M | $ -2.10M | $ 0 | $ 1.17M |
| 2016 | $ 0 | $ -4.60M | $ -477.5K | $ 19.5K | $ 834.4K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | -1.00 |
| Current Ratio | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/LXGTF.md)
- [Charts](https://sponda.capital/en/LXGTF/charts.md)
- [Compare](https://sponda.capital/en/LXGTF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.